![Christopher Landeg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Landeg
Director de Operaciones en Quotient Sciences (Reading) Ltd. .
Cargos activos de Christopher Landeg
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Quotient Sciences (Reading) Ltd.
![]() Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Director/Miembro de la Junta | - | - |
Director de Operaciones | - | - |
Historial de carrera de Christopher Landeg
Estadísticas
Internacional
Reino Unido | 2 |
Operativa
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Quotient Sciences (Reading) Ltd.
![]() Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Landeg
- Experiencia